Nitricap Medical Inc. — Form D
Nitricap Medical Inc. of MINNEAPOLIS, MN, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-13. The offering totals $5.0M, of which $3.2M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-04-13
- Form: D
- Accession: 0001235802-21-000019
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.2M
- Remaining: $1.8M
- Investors: 16
- Date of first sale: 2021-03-31
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-395619
Issuer
- Name: Nitricap Medical Inc.
- CIK: 0001849630
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 333 E. HENNEPIN AVENUE, MINNEAPOLIS, MN, 55414
- Phone: 860-227-2717
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Paul Rabinovich | Director | Minneapolis, MN |
| Alexander Yevzlin | Director | Neenah, WI |
| John Zentgraf | Director | Minneapolis, MN |
| Paul Rabinovich | Executive Officer | Minneapolis, MN |
| Alexander Yevzlin | Executive Officer | Neenah, WI |
| John Zentgraf | Executive Officer | Minneapolis, MN |
More